Ardelyx (ARDX) Cash from Operations Growth (1y) (2014 - 2026)
Ardelyx (ARDX) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ardelyx |
1.49 Bn |
1.25 Bn |
89.66 Mn |
16.17% |
| Date | Value |
|---|
| Mar 31, 2026 |
16.17% |
| Dec 31, 2025 |
113.57% |
| Sep 30, 2025 |
-27.15% |
| Jun 30, 2025 |
-30.64% |
| Mar 31, 2025 |
-7.66% |
| Dec 31, 2024 |
212.53% |
| Sep 30, 2024 |
102.33% |
| Jun 30, 2024 |
-31.63% |
| Mar 31, 2024 |
20.25% |
| Dec 31, 2023 |
-161.03% |
| Sep 30, 2023 |
15.57% |
| Jun 30, 2023 |
52.89% |
| Mar 31, 2023 |
-62.18% |
| Dec 31, 2022 |
136.19% |
| Sep 30, 2022 |
26.49% |
| Jun 30, 2022 |
8.74% |
| Mar 31, 2022 |
37.54% |
| Dec 31, 2021 |
-124.38% |
| Sep 30, 2021 |
-74.02% |
| Jun 30, 2021 |
-80.19% |
